StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Impact BioMedical's market cap was $26.05M on Oct 19, 2026, against $514.77K a year earlier. Over the last 2 years it ranged from $387.80K to $47.67M, with a median of $1.58M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$26.05M+5261.6%
2025Dec 31, 2025$485.81K-63.1%
2024Dec 31, 2024$1.32M–

More Impact BioMedical figures

See a number that looks wrong?